BRIEF-Eli Lilly sees potential launch of 20 new drugs through 2023

* CFO says does not see U.S. healthcare reform changes impacting 2017 sales
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.